1
/
of
1
Elabscience
SKU:PKSH033625
Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active)
Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active), a cutting-edge product meticulously engineered to revolutionize the field of immunotherapy. This exceptional protein, derived from advanced recombinant technology, showcases remarkable potency and efficacy in enhancing immune responses.
Crafted with utmost precision, this mutant variant of Human Interleukin-2 (IL-2) exhibits unparalleled activity, surpassing conventional IL-2 proteins. Its unique composition enables it to interact with immune cells, stimulating their proliferation and activation, thereby bolstering the body's defense mechanisms against various diseases.
The Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active) is a result of rigorous research and development, ensuring its exceptional quality and reliability. It adheres to the highest industry standards, guaranteeing consistent performance and reproducibility in diverse experimental settings.
This groundbreaking protein holds immense potential in the field of cancer immunotherapy, as it can effectively enhance the anti-tumor immune response. By activating and expanding cytotoxic T cells and natural killer cells, it empowers the immune system to recognize and eliminate malignant cells, offering a promising avenue for cancer treatment.
Furthermore, this remarkable protein exhibits remarkable stability and solubility, facilitating its easy handling and storage. Its active form ensures optimal functionality, enabling researchers and clinicians to explore its vast therapeutic applications with utmost confidence.
In summary, the Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active) represents a significant breakthrough in immunotherapy. Its exceptional potency, reliability, and versatility make it an indispensable tool for researchers and healthcare professionals alike, propelling advancements in the field of immune modulation and disease treatment. Embrace this cutting-edge protein and unlock new possibilities in the realm of immunotherapy.
Crafted with utmost precision, this mutant variant of Human Interleukin-2 (IL-2) exhibits unparalleled activity, surpassing conventional IL-2 proteins. Its unique composition enables it to interact with immune cells, stimulating their proliferation and activation, thereby bolstering the body's defense mechanisms against various diseases.
The Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active) is a result of rigorous research and development, ensuring its exceptional quality and reliability. It adheres to the highest industry standards, guaranteeing consistent performance and reproducibility in diverse experimental settings.
This groundbreaking protein holds immense potential in the field of cancer immunotherapy, as it can effectively enhance the anti-tumor immune response. By activating and expanding cytotoxic T cells and natural killer cells, it empowers the immune system to recognize and eliminate malignant cells, offering a promising avenue for cancer treatment.
Furthermore, this remarkable protein exhibits remarkable stability and solubility, facilitating its easy handling and storage. Its active form ensures optimal functionality, enabling researchers and clinicians to explore its vast therapeutic applications with utmost confidence.
In summary, the Recombinant Human Interleukin-2/IL-2 Protein (Mutant)(Active) represents a significant breakthrough in immunotherapy. Its exceptional potency, reliability, and versatility make it an indispensable tool for researchers and healthcare professionals alike, propelling advancements in the field of immune modulation and disease treatment. Embrace this cutting-edge protein and unlock new possibilities in the realm of immunotherapy.
Share
